NeuroOne-Logo.png

10006 Liatris Lane
Eden Prairie, MN 55347

www.neurooneinc.com

Facilitated Growth was engaged by NeuroOne
Medical Technologies in Summer 2018. The publicly-held, development-stage company (OTC:NMTC) 
offers advanced diagnostic/therapeutic technologies for patients with neurological disorders of the brain. 

 

Facilitated Growth advised the company through its first private investment, public equity financing initiative and continues to assist with the development of economic and capitalization strategies. Facilitated Growth maintains its position as an active advisor and is optimistic about the company's expanding developments.

CEO: Dave Rosa

CDO: Mark Christianson

FG Consultant: Sarah Dickson

To learn more about NeuroOne Medical Technologies Corp. or Facilitated Growth's relationship with this company, please contact Joe Soto or Sarah Dickson.

sarah-bw.png

Sarah Dickson

VP of Operations

Facilitated Growth

Joe Soto

CEO

Facilitated Growth

About The Company

NeuroOne Medical Technologies Inc. is a medical technology company, focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy.

 

NeuroOne has a robust and growing intellectual property portfolio for a pipeline of products in various stages of development. Their current focus is on patented thin-film, cortical electrode technology for iEEG and depth electrodes for sEEG recording of brain activity. 

NeuroOne can address unmet needs upon initial commercialization of technology that enables minimally invasive techniques and all-in-one diagnostic/therapeutic options. 

About The Technology
NeuroOne's patented Cortical Electrodes use a significantly thinner substrate that better conforms to the recording surface. Advanced materials reduce brain swelling and better detect micro-seizures for faster diagnosis. The technology allows for improved resection planning, as well as minimally invasive placement through disposable, sterile cable.
NeuroOne's patented Depth Electrodes can better detect microseizures, allow for high-resolution recording, utilize disposable, sterile cable, and offer second generation technology through a single device.
All of these technologies aid in expediting diagnoses, reducing costs, increasing accuracy, decreasing the risk of infection, and improving patient outcomes. 

Learn more about NeuroOne Medical Technologies. Simply hover over the images above to read about the company and/or products.